Differences between men and women in ambulatory blood pressure thresholds for diagnosis of hypertension based on cardiovascular outcomes

Chronobiology International

Volumn 30, Issue 1-2, 2013, Pages 221-232

  Hermida, Ramón C ^a   Ayala, Diana E ^a   Mojón, Artemio ^a   Fontao, María J ^a   Chayán, Luisa ^a   Fernández, José R ^a  

^a UNIVERSITY OF VIGO   (Spain)

Author keywords

Ambulatory blood pressure; Cardiovascular risk; Diagnostic thresholds; Sex differences

Indexed keywords

ACTIMETRY; ADULT; AGED; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; CARDIOVASCULAR DISEASE; CIRCADIAN RHYTHM; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLE; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; MALE; METHODOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SEX DIFFERENCE; SYSTOLE; TREATMENT OUTCOME;

ACTIGRAPHY; ADULT; AGED; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CARDIOVASCULAR DISEASES; CIRCADIAN RHYTHM; DIASTOLE; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; SYSTOLE; TREATMENT OUTCOME;

EID: 84874130312     PISSN: 07420528     EISSN: 15256073     Source Type: Journal    
DOI: 10.3109/07420528.2012.701487     Document Type: Article

References (92)

1. Alli C, Avanzini F, Bettelli G, Colombo F, Torri V, Tognoni G, general practitioners of SPAA. (1999). The long-term prognostic significance of repeated blood pressure measurements in the elderly: SPAA (Studio sulla Pressione Arteriosa nell'Anziano) 10-year follow-up. Arch. Intern. Med. 159:1205-1212. (Pubitemid 29269860)
2. American Diabetes Association. (2007). Diagnosis and classification of diabetes mellitus. Diabetes Care 30(Suppl 1):S42-S47.
3. Ayala DE, Hermida RC, Mojón A, Fernández Jr. (2013). Cardiovascular risk of resistant hypertension: Dependence on treatment-time regimen of blood pressure-lowering medications. Chronobiol. Int. 30:340-352.
4. Ben-Dov IZ, Kark JD, Ben-Ishay D, Mekler J, Ben-Arie L, Bursztyn M. (2007). Predictors of all-cause mortality in clinical ambulatory monitoring. Unique aspects of blood pressure during sleep. Hypertension 49:1235-1241. (Pubitemid 46809363)
5. Ben-Dov IZ, Mekler J, Bursztyn M. (2008). Sex differences in ambulatory blood pressure monitoring. Am. J. Med. 121:509-514. (Pubitemid 351694341)
6. Boggia J, Li Y, Thijs L, Hansen TW, Kikuya M, Björklund- Bodegård K, Richart T, Ohkubo T, Kuznetsova T, Torp-Pedersen CH, Lind L, Ibsen H, Imai Y, Wang J, Sandoya E, O'Brien E, Staessen JA. (2007). Prognostic accuracy of day versus night ambulatory blood pressure: A cohort study. Lancet 370:1219-1229. (Pubitemid 47503300)
7. Bouhanick B, Bongard V, Amar J, Bousquel S, Chamontin B. (2008). Prognostic value of nocturnal blood pressure and reverse-dipping status on the occurrence of cardiovascular events in hypertensive diabetic patients. Diabetes Metab. 34:560-567.
8. Bur A, Herkner H, Vlcek M, Woisetschläger C, Derhaschnig U, Hirschl MM. (2002). Classification of blood pressure levels by ambulatory blood pressure in hypertension. Hypertension 40:817-822. (Pubitemid 35434900)
9. Burt VL Whelton P. Roccella EJ, Brown C, Cutler JA, Higgins M, Horan MJ, Labarthe D. (1995). Prevalence of hypertension in the US adult population: results of the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 25:305-313.
10. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jones DW, Materson BJ, Oparil S, Wright JT, Rocella EJ, and the National High Blood Pressure Education Coordinating Committee. (2003). The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. JAMA 289:2560-2571.
11. Clement DL, De Buyzere ML, De Bacquer DA, de Leeuw PW, Duprez DA, Fagard RH, Gheeraert PJ, Missault LH, Braun JJ, Six RO, Van Der Niepen P, O'Brien E. (2003). Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension. N. Engl. J. Med. 348:2407-2415. (Pubitemid 36682819)
12. Coylewright M, Reckelhoff JF, Ouyang P. (2008). Menopause and hypertension: an age-old debate. Hypertension 51:952-959. (Pubitemid 351398967)
13. Crespo C, Aboy M, Fernández JR, Mojón A. (2012). Automatic identification of activity-rest periods based on actigraphy. Med. Biol. Eng. Comput. 50:329-340.
14. Crespo C, Fernández JR, Aboy M, Mojón A. (2013). Clinical application of a novel automatic algorithm for actigraphy-based activity and rest period identification to accurately determine awake and asleep ambulatory blood pressure parameters and cardiovascular risk. Chronobiol. Int. 30:43-54.
15. Dolan E, Stanton A, Thijs L, Hinedi K, Atkins N, McClory S, Den Hond E, McCormack P, Staessen JA, O'Brien E. (2005). Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: The Dublin outcome study. Hypertension 46:156-161. (Pubitemid 40946507)
16. Eguchi K, Pickering TG, Hoshide S, Ishikawa J, Ishikawa S, Schwartz J, Shimada K, Kario K. (2008). Ambulatory blood pressure is a better marker than clinic blood pressure in predicting cardiovascular events in patients with/without type 2 diabetes. Am. J. Hypertens. 21:443-450. (Pubitemid 351450870)
17. Fagard RH, Celis H, Thijs L, Staessen JA, Clement DL, De Buyzere ML, De Bacquer DA. (2008). Daytime and nighttime blood pressure as predictors of death and cause-specific cardiovascular events in hypertension. Hypertension 51:55-61. (Pubitemid 350307104)
18. Fan HQ, Li Y, Thijs L, Hansen TW, Boggia J, KikuyaM, Björklund- Bodegard K, Richart T, Ohkubo T, Jeppesen J, Torp-Pedersen C, Dolan E, Kuznetsova T, Stolarz-Skrzypek K, Tikhonoff V, Malyutina S, Casiglia E, Nikitin Y, Lind L, Sandoya E, Kawecka-Jaszcz K, Imai Y, Ibsen H, O'Brien E, Wang J, Staessen JA. (2010). Prognostic value of isolated nocturnal hypertension on ambulatory measurement in 8711 individuals from 10 populations. J. Hypertens. 28:2036-2045.
19. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Frauss RM, Savage PJ, Smith SC, Spertus JA, Costa F. (2005). Diagnosis and management of the metabolic syndrome. An American heart Association/national heart, lung, and blood institute scientific statement. Circulation 112:2735-2752. (Pubitemid 41532612)
20. Hansen TW, Kikuya M, Thijs L, Li Y, Boggia J, Björklund- Bodegârd K, Torp-Pedersen C, Jeppesen J, Ibsen H, Staessen JA. (2008). Diagnostic thresholds for ambulatory blood pressure moving lower: A review based on a meta-analysis-clinical implications. J. Clin. Hypertens. (Greenwich) 10:377-381.
21. Head GA, Mihailidou AS, Duggan KA, Beilin LJ, Berry N, Brown MA, Bune AJ, Cowley D, Chalmers JP, Howe PR, Hodgson J, Ludbrook J, Mangoni AA, McGrath BP, Nelson MR, Sharman JE, Stowasser M, Ambulatory Blood Pressure Working Group of the High Blood Pressure Research Council of Australia. (2010). Definition of ambulatory blood pressure targets for diagnosis and treatment of hypertension in relation to clinic blood pressure: prospective cohort study. BMJ 340:c1104. doi: 10.1136/bmj.c1104, 1-8.
22. Head GA, McGrath BP, Mihailidou AS, Nelson MR, Schlaich MP, Stowasser M, Mangoni AA, Cowley D, Brown MA, Ruta LA, Wilson A 2012 Ambulatory blood pressure monitoring in Australiarfpy1 2011 consensus position statement. J. Hypertens. 30:253-266.
23. Hermida RC. (1999). Time-qualified reference values for 24 h ambulatory blood pressure monitoring. Blood Press. Monit. 4:137-147.
24. Hermida RC. (2007). Ambulatory blood pressure monitoring in the prediction of cardiovascular events and effects of chronotherapy: rationale and design of the MAPEC study. Chronobiol. Int. 24:749-775. (Pubitemid 47263103)
25. Hermida RC, Ayala DE. (2003). Sampling requirements for ambulatory blood pressure monitoring in the diagnosis of hypertension in pregnancy. Hypertension 42:619-624. (Pubitemid 37237363)
26. Hermida RC, Fernández Jr. (1996). Computation of time-specified tolerance intervals for ambulatorily monitored blood pressure. Biomed. Instrum. Technol. 30:257-266. (Pubitemid 26161490)
27. Hermida RC, Smolensky MH. (2004). Chronotherapy of hypertension. Curr. Opin. Nephrol. Hypertens. 13:501-505. (Pubitemid 39150075)
28. Hermida RC, Mojón A, Fernández JR, Ayala DE. (1996). Computerbased medical system for the computation of blood pressure excess in the diagnosis of hypertension. Biomed. Instrum. Technol. 30:267-283. (Pubitemid 26161491)
29. Hermida RC, Fernández JR, Mojón A, Ayala DE. (2000). Reproducibility of the hyperbaric index as a measure of blood pressure excess. Hypertension 35:118-125. (Pubitemid 30054247)
30. Hermida RC, Ayala DE, Fernández JR, Mojón A, Alonso I, Calvo C. (2002a). Modeling the circadian variability of ambulatorily monitored blood pressure by multiple-component analysis. Chronobiol. Int. 19:461-481. (Pubitemid 34478039)
31. Hermida RC, Calvo C, Ayala DE, Fernández JR, Ruilope LM, López JE. (2002b). Evaluation of the extent and duration of the "ABPM effect" in hypertensive patients. J. Am. Coll. Cardiol. 40:710-717. (Pubitemid 34925618)
32. Hermida RC, Calvo C, Ayala DE, Mojón A, López JE. (2002c). Relationship between physical activity and blood pressure in dipper and nondipper hypertensive patients. J. Hypertens. 20:1097-1104. (Pubitemid 34913627)
33. Hermida RC, Mojón A, Fernández JR, Alonso I, Ayala DE. (2002d). The tolerance-hyperbaric test: A chronobiologic approach for improved diagnosis of hypertension. Chronobiol. Int. 19:1183-1211. (Pubitemid 36008225)
34. Hermida RC, Calvo C, Ayala DE, Domínguez MJ, Covelo M, Fernández JR, Fontao MJ, López JE. (2004a). Administration-time- dependent effects of doxazosin GITS on ambulatory blood pressure of hypertensive subjects. Chronobiol. Int. 21:277-296. (Pubitemid 39014625)
35. Hermida RC, Fernández JR, Ayala DE, Mojón A, Alonso I, Calvo C. (2004b). Circadian time-qualified tolerance intervals for ambulatory blood pressure monitoring in the diagnosis of hypertension. Chronobiol. Int. 21:149-170.
36. Hermida RC, Ayala DE, Calvo C. (2005). Administration time-dependent effects of antihypertensive treatment on the circadian pattern of blood pressure. Curr. Opin. Nephrol. Hypertens. 14:453-459. (Pubitemid 41152708)
37. Hermida RC, Ayala DE, Calvo C, Portaluppi F, Smolensky MH. (2007). Chronotherapy of hypertension: administration-time dependent effects of treatment on the circadian pattern of blood pressure. Adv. Drug Deliv. Rev. 59:923-939. (Pubitemid 47531897)
38. Hermida RC, Ayala DE. Fernandez JR, Mojón A, Calvo C. (2007). Influence of measurement duration and frequency on ambulatory blood pressure monitoring. Rev. Esp. Cardiol. 60:131-138. (Pubitemid 46566967)
39. Hermida RC, Ayala DE, Portaluppi F. (2007c). Circadian variation of blood pressure: The basis for the chronotherapy of hypertension. Adv. Drug Deliv. Rev. 59:904-922. (Pubitemid 47534216)
40. Hermida RC, Ayala DE, Mojón A, Fernández Jr. (2010). Influence of circadian time of hypertension treatment on cardiovascular risk: results of the MAPEC study. Chronobiol. Int. 27:1629-1651.
41. Hermida RC, Ayala DE, Fernández JR, Portaluppi F, Fabbian F, Smolensky MH. (2011a). Circadian rhythms in blood pressure regulation and optimization of hypertension treatment with ACE inhibitor and ARB medications. Am. J. Hypertens. 24:383-391.
42. Hermida RC, Ayala DE, Mojón A, Fernández Jr. (2011b). Influence of time of day of blood pressure-lowering treatment on cardiovascular risk in hypertensive patients with type 2 diabetes. Diabetes Care 34:1270-1276.
43. Hermida RC, Ayala DE, Mojón A, Fernández Jr. (2011c). Decreasing sleep-time blood pressure determined by ambulatory monitoring reduces cardiovascular risk. J. Am. Coll. Cardiol. 58:1165-1173.
44. Hermida RC, Ayala DE, Mojón A, Fernández Jr. (2011d). Bedtime dosing of antihypertensive medications reduces cardiovascular risk in CKD. J. Am. Soc. Nephrol. 22:2313-2321.
45. Hermida RC, Ayala DE, Mojón A, Fernández Jr. (2012a). Sleep-time blood pressure and the prognostic value of isolated-office and masked hypertension. Am. J. Hypertens. 25:297-305.
46. Hermida RC, Ayala DE, Mojón A, Fernández Jr. (2012b). Sleep-time blood pressure as a therapeutic target for cardiovascular risk reduction in type 2 diabetes. Am. J. Hypertens. 25:325-334.
47. Hermida RC, Ayala DE, Fernández JR, Mojón A. (2013a). Sleeptime blood pressure: prognostic value and relevance as a therapeutic target for cardiovascular risk reduction. Chronobiol. Int. 30:68-86.
48. Hermida RC, Ayala DE, Fernández JR, Mojón A, Smolensky MH, Fabbian F, Portaluppi F. (2013b). Administration-time differences in effects of hypertension medications on ambulatory blood pressure regulation. Chronobiol. Int. 30:280-314.
49. Hermida RC, Ayala DE, Fontao MJ, Mojón A, Fernández Jr. (2013). Ambulatory blood pressure monitoring: importance of sampling rate and duration - 48 versus 24 hours - on the accurate assessment of cardiovascular risk. Chronobiol. Int. 30:55-67.
50. Hermida RC, Ayala DE, Mojón A, Fernández Jr. (2013d). Cardiovascular risk of essential hypertension: influence of class, number, and treatment-time regimen of hypertension medications. Chronobiol. Int. 30:315-327.
51. Hermida RC, Ayala DE, Mojón A, Fernández Jr. (2013e). Blunted sleep-time relative blood pressure decline increases cardiovascular risk independent of blood pressure level - the "normotensive nondipper" paradox. Chronobiol Int. 30: 87-98.
52. Hermida RC, Ayala DE, Mojón A, Fernández Jr. (2013f). Role of timeof-day of hypertension treatment on the J-shaped relationship between blood pressure and cardiovascular risk. Chronobiol. Int. 30:328-339.
53. Kagan A, Faibel H, Ben-Arie G, Granevitze Z, Rapoport J. (2007). Gender differences in ambulatory blood pressure monitoring profile in obese, overweight and normal subjects. J. Hum. Hypertens. 21:128-134.
54. Kikuya M, Ohkubo T, Asayama K, Metoki H, Obara T, Saito S, Hashimoto J, Totsune K, Hoshi H, Satoh H, Imai Y. (2005). Ambulatory blood pressure and 10-year risk of cardiovascular and noncardiovascular mortality. The Ohasama Study. Hypertension 45:240-245. (Pubitemid 40179967)
55. Kikuya M, Hansen TW, Thijs L, Björklund-Bodegård K, Kuznetsova T, Ohkubo T, Richart T, Torp-Pedersen C, Lind L, Ibsen H, Imai Y, Staessen JA, International Database on Ambulatory blood pressure monitoring in relation to Cardiovascular Outcomes Investigators. (2007). Diagnostic thresholds for ambulatory blood pressure monitoring based on 10-year cardiovascular risk. Circulation 115:2145-2152. (Pubitemid 46659066)
56. Levey AS, Stevens LA, Schmid CH, Zhang Y, Castro AF, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J, for the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI). (2009). A new equation to estimate glomerular filtration rate. Ann. Intern. Med. 150:604-612.
57. Lloyd-Jones DM, Evans JC, Levy D. (2005). Hypertension in adults across the age spectrum: current outcomes and control in the community. JAMA 294:466-472. (Pubitemid 41124179)
58. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder RE, Struijker HAJ, Zanchetti A. (2007). 2007 guidelines for the management of arterial hypertension. The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J. Hypertens. 25:1105-1187. (Pubitemid 46924065)
59. Manfredini R, Portaluppi F, Grandi E, Fersini C, Gallerani M. (1996). Out-of-hospital sudden death referring to an emergency department. J. Clin. Epidemiol. 49:865-868. (Pubitemid 26283397)
60. Manfredini R, Portaluppi F, Salmi R, Zamboni P, La Cecilia O, Kuwornu-Afi H, Regoli F, Bigoni M, Gallerani M. (1999). Seasonal variation in the occurrence of non traumatic rupture of thoracic aorta. Am. J. Emerg. Med. 17:672-674.
61. Manfredini R, Boari B, Bressan S, Gallerani M, Salmi R, Portaluppi F, Mehta RH. (2004). Influence of circadian rhythm on mortality after myocardial infarction: Data from a prospective cohort of emergency calls. Am. J. Emerg. Med. 22:555-559. (Pubitemid 40143236)
62. Manfredini R, Fabbian F, Pala M, Tiseo R, De Giorgi A, Manfredini F, Malagoni AM, Signani F, Andreati C, Boari B, Salmi R, Imberti D, Gallerani M. (2011). Seasonal and weekly patterns of occurrence of acute cardiovascular diseases: Does a gender difference exist? J. Womens Health 20:1663-1668.
63. Meininger JC, Liehr P, Chan W, Smith G, Mueller WH. (2004). Developmental, gender, and ethnic group differences in moods and ambulatory blood pressure in adolescents. Ann. Behav. Med. 28:10-19. (Pubitemid 38988530)
64. Minutolo R, Agarwal R, Borrelli S, Chiodini P, Bellizzi V, Nappi F, Cianciaruso B, Zamboni P, Conte G, Gabbai FB, De Nicola L. (2011). Prognostic role of ambulatory blood pressure measurement in patients with nondialysis chronic kidney disease. Arch. Intern. Med. 171:1090-1098.
65. National Institute for Health and Clinical Excellence. (2011). Hypertension: The clinical management of primary hypertension in adults. Clinical guideline: Methods, evidence and recommendations. Accessed April 24, 2012, from http://guidance.nice.org. uk/CG/Wave2/14.
66. National Kidney Foundation. (2002). K/DOQI clinical practice guidelines on chronic kidney disease: Evaluation, classification and stratification. Am. J. Kidney Dis. 39(2 Suppl 1):S1-S266.
67. Ohkubo T, Imai Y, Tsuji I, Nagai K, Ito S, Satoh H, Hisamichi S. (1998). Reference values for 24-hour ambulatory blood pressure monitoring based on a prognostic criterion: The Ohasama Study. Hypertension 32:255-259. (Pubitemid 28376481)
68. Ong KL, Tso AW, Lam KS, Cheung BM. (2008). Gender difference in blood pressure control and cardiovascular risk factors in Americans with diagnosed hypertension. Hypertension 51:1142-1148. (Pubitemid 351398962)
69. Palatini P, Mos L, Santonastaso M, Saladini F, Benetti E, Mormino P, Bortolazzi A, Cozzio S. (2001). Premenopausal women have increased risk of hypertensive target organ damage compared with men of similar age. J. Womens Health (Larchmt.) 20:1175-1181.
70. Perloff D, Sokolow M, Cowan R. (1983). The prognostic value of ambulatory blood pressures. JAMA 249:2792-2798. (Pubitemid 13093711)
71. Pimenta E. Hypertension in women. (2012). Hypertens. Res. 35:148-152.
72. Portaluppi F, Hermida RC. (2007). Circadian rhythms in cardiac arrhythmias and opportunities for their chronotherapy. Adv. Drug Deliv. Rev. 59:940-951. (Pubitemid 47534217)
73. Portaluppi F, Smolensky MH. (2000). Circadian rhythm and environmental determinants of blood pressure regulation in normal and hypertensive conditions. In White WB (Ed.). Blood Pressure monitoring in cardiovascular medicine and therapeutics. Totowa, NJ: Humana Press, 79-118.
74. Portaluppi F, Smolensky MH. (2010). Perspectives on the chronotherapy of hypertension based on the results of the MAPEC study. Chronobiol. Int. 27:1652-1667.
75. Portaluppi F, Montanari L, Ferlini M, Gilli P. (1990). Altered circadian rhythms of blood pressure and heart rate in non-hemodialysis chronic renal failure. Chronobiol. Int. 7:321-327.
76. Portaluppi F, Trasforini G, Margutti A, Vergnani L, Ambrosio MR, Rossi R, Bagni B, Pansini R, degli Uberti EC. (1992). Circadian rhythm of calcitonin gene-related peptide in uncomplicated essential hypertension. J. Hypertens. 10:1227-1234.
77. Portaluppi F, Cortelli P, Avoni P, Vergnani L, Maltoni P, Pavani A, Sforza E, degli Uberti EC, Gambetti P, Lugaresi E. (1994). Progressive disruption of the circadian rhythm of melatonin in fatal familial insomnia. J. Clin. Endocrinol. Metab. 78:1075-1078. (Pubitemid 24143026)
78. Portaluppi F, Vergnani L, Manfredini R, Fersini C. (1996). Endocrine mechanisms of blood pressure rhythms. Ann. N. Y. Acad. Sci. 783:113-131. (Pubitemid 26372085)
79. Portaluppi F, Pansini F, Manfredini R, Mollica G. (1997). Relative influence of menopausal status, age, and body mass index on blood pressure. Hypertension 29:976-979. (Pubitemid 27152468)
80. Portaluppi F, Boari B, Manfredini R. (2004). Oxidative stress in essential hypertension. Curr. Pharm. Des. 10:1695-1698. (Pubitemid 38559779)
81. Portaluppi F, Smolensky MH, Touitou Y. (2010). Ethics and methods for biological rhythm research on animals and human beings. Chronobiol. Int. 27:1911-1929.
82. Portaluppi F, Tiseo R, Smolensky MH, Hermida RC, Ayala DE, Fabbian F. (2012). Circadian rhythms and cardiovascular health. Sleep Med. Rev. 16:151-166.
83. Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM, Carnethon MR, Dai S, de Simone G, Ford ES, Fox CS, Fullerton HJ, Gillespie C, Greenlund KJ, Hailpern SM, Heit JA, Ho PM, Howard VJ, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Makuc DM, Marcus GM, Marelli A, Matchar DB, McDermott MM, Meigs JB, Moy CS, Mozaffarian D, Mussolino ME, Nichol G, Paynter NP, Rosamond WD, Sorlie PD, Stafford RS, Turan TN, Turner MB, Wong ND, Wylie-Rosett J. (2011). Heart disease and stroke statistics - 2011 update: A report from the American Heart Association. Circulation 123: E18-e209.
84. Salles GF, Cardoso CR, Muxfeldt ES. (2008). Prognostic influence of office and ambulatory blood pressures in resistant hypertension. Arch. Intern. Med. 168:2340-2346.
85. Smolensky MH, Portaluppi F. (1999). Chronopharmacology and chronotherapy of cardiovascular medications: relevance to prevention and treatment of coronary heart disease. Am. Heart J. 137(4 Pt 2):S14-S24. (Pubitemid 29162888)
86. Smolensky MH, Hermida RC, Castriotta RJ, Portaluppi F. (2007). Role of sleep-wake cycle on blood pressure circadian rhythms and hypertension. Sleep Med. 8:668-680. (Pubitemid 47192885)
87. Smolensky MH, Hermida RC, Ayala DE, Tiseo R, Portaluppi F. (2010). Administration-time-dependent effect of blood pressure-lowering medications: basis for the chronotherapy of hypertension. Blood Press. Monit. 15:173-180.
88. Trasforini G, Margutti A, Portaluppi F, Menegatti M, Ambrosio MR, Bagni B, Pansini R, degli Uberti EC. (1991). Circadian profile of plasma calcitonin gene-related peptide in healthy man. J. Clin. Endocrinol. Metab. 73:945-951. (Pubitemid 21901129)
89. Varani K, Gessi S, Caiazza A, Rastelli G, Portaluppi F, Borea PA. (1999). Platelet alpha2-adrenoceptor alterations in patients with essential hypertension. Br. J. Clin. Pharmacol. 47:167-172. (Pubitemid 29078015)
90. Verdecchia P, Porcellati C, Schillaci G, Borgioni C, Ciucci A, Battistell M, Guerrieri M, Gatteschi C, Zampi I, Santucci A, Santucci C, Reboldi G. (1994). Ambulatory blood pressure: an independent predictor of prognosis in essential hypertension. Hypertension 24:793-801. (Pubitemid 24363980)
91. Vriz O, Lu H, Visentin P, Nicolosi L, Mos L, Palatini P. (1997). Gender differences in the relationship between left ventricular size and ambulatory blood pressure in borderline hypertension. The HARVEST Study. Eur. Heart J. 18:664-670. (Pubitemid 27182361)
92. Wang X, Poole JC, Treiber FA, Harshfield GA, Hanevold CD, Snieder H. (2006). Ethnic and gender differences in ambulatory blood pressure trajectories: results from a 15-year longitudinal study in youth and young adults. Circulation 114:2780-2787. (Pubitemid 46018280)